DE2052131A1 - Präparat - Google Patents

Präparat

Info

Publication number
DE2052131A1
DE2052131A1 DE19702052131 DE2052131A DE2052131A1 DE 2052131 A1 DE2052131 A1 DE 2052131A1 DE 19702052131 DE19702052131 DE 19702052131 DE 2052131 A DE2052131 A DE 2052131A DE 2052131 A1 DE2052131 A1 DE 2052131A1
Authority
DE
Germany
Prior art keywords
acid
garcinic
lactone
derivative
ester
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19702052131
Other languages
German (de)
English (en)
Inventor
John M Wellesley Hills Mass Lowenstein (V St A )
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of DE2052131A1 publication Critical patent/DE2052131A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19702052131 1969-10-29 1970-10-23 Präparat Pending DE2052131A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87241369A 1969-10-29 1969-10-29

Publications (1)

Publication Number Publication Date
DE2052131A1 true DE2052131A1 (de) 1971-05-06

Family

ID=25359519

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19702052131 Pending DE2052131A1 (de) 1969-10-29 1970-10-23 Präparat

Country Status (9)

Country Link
BE (1) BE758122A (xx)
CA (1) CA923425A (xx)
DE (1) DE2052131A1 (xx)
FR (1) FR2070174B1 (xx)
GB (1) GB1311015A (xx)
IE (1) IE34648B1 (xx)
IL (1) IL35477A (xx)
NL (1) NL7015348A (xx)
ZA (1) ZA706931B (xx)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2716374A1 (fr) * 1994-02-18 1995-08-25 Sederma Sa Nouvelles compositions cosmétiques ou dermopharmaceutiques contenant des extraits de plantes.
EP0787489A2 (en) * 1995-12-15 1997-08-06 Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. Composition containing L-carnitine or alkanoyl-L-carnitine and hydroxycitric acid or pantothenic acid

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE792180A (fr) * 1971-12-02 1973-06-01 Hoffmann La Roche Derives de l'acide citrique
ES2106689B1 (es) * 1996-04-18 1998-05-16 Cabo Soler Jose Nueva formulacion a base de acido hidroxicitrico (sales y derivados) y sus aplicaciones cosmeticas y farmaceuticas por via topica percutanea.
US20030004215A1 (en) * 2001-06-15 2003-01-02 Van Laere Katrien Maria Jozefa Dietetic preparation and method for inhibiting intestinal carbohydrate absorption

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2716374A1 (fr) * 1994-02-18 1995-08-25 Sederma Sa Nouvelles compositions cosmétiques ou dermopharmaceutiques contenant des extraits de plantes.
EP0787489A2 (en) * 1995-12-15 1997-08-06 Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. Composition containing L-carnitine or alkanoyl-L-carnitine and hydroxycitric acid or pantothenic acid
EP0787489A3 (xx) * 1995-12-15 1997-09-10 Sigma Tau Ind Farmaceuti

Also Published As

Publication number Publication date
NL7015348A (xx) 1971-05-04
FR2070174A1 (xx) 1971-09-10
IL35477A (en) 1973-08-29
IL35477A0 (en) 1970-12-24
FR2070174B1 (xx) 1974-02-22
BE758122A (fr) 1971-04-28
GB1311015A (en) 1973-03-21
ZA706931B (en) 1971-07-28
IE34648B1 (en) 1975-07-09
CA923425A (en) 1973-03-27
IE34648L (en) 1971-04-29

Similar Documents

Publication Publication Date Title
US3764692A (en) Method of treating obesity
DE68910386T2 (de) Nicht-beta-oxidierbare Fettsäure-Analoge, die die Blutkonzentration von Cholesterin und Triglyceriden bei Säugetieren senken.
DE2910221C2 (xx)
DE69031033T2 (de) Verwendung von eicosapentaensäure zur behandlung der kachexie
DE3752112T2 (de) Verwendung von Inositoltriphosphat zur Behandlung von Entzündungen
EP0044801B1 (de) Nichthygroskopische Salze der 4-Hydroxybuttersäure, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung pharmazeutischer Mittel
DE69034181T2 (de) Kapsel, enthaltend ein Dioxabicyclo(3.3.0)oktan
DE19653225A1 (de) Kreatin-pyruvate und Verfahren zu deren Herstellung
DE2141634C3 (de) Neue Isoindolinderivate, ihre Herstellung und Zusammensetzungen, die sie enthalten
DE2821242C2 (xx)
DE60129032T2 (de) Creatinester-pronutrient-verbindungen und formulierungen
DE3907688C2 (de) Salze von ungesättigten Fettsäuren mit Aminosäuren, Verfahren zu ihrer Herstellung sowie die Verwendung der ersteren und von weiteren derartigen Salzen
DE2052131A1 (de) Präparat
DE2625012C3 (de) Arzneimittel zur Kontrolle von Leberkrankheiten
DE2258255A1 (de) Citronensaeurederivate
CH624098A5 (xx)
DE1932389C3 (xx)
DE2723876C2 (de) 17β-Ester von Testosteron
CH621780A5 (xx)
DE1593096B2 (xx)
DE3021169C2 (de) Pivaloyloxymethyl-2-propylpentanoat, Verfahren zu seiner Herstellung und diese Verbindung enthaltende Arzneimittel
AT395818B (de) Auf das herz-kreislauf-system wirkende arzneimittelpraeparate und verfahren zur herstellung derselben
DE2703652C2 (xx)
DE2318784A1 (de) N-(2,4-dihydroxybenzoyl)-4-aminosalizylsaeure
DE2038836C3 (de) Arzneimittel

Legal Events

Date Code Title Description
OHW Rejection